新华医疗：高端精密微创手术器械生产扩建项目实施主体股权结构变更

Core Viewpoint - The company announced a board meeting on November 28, 2025, to approve changes in the equity structure of the implementation entity for a high-end precision minimally invasive surgical instrument production expansion project [1] Group 1: Project Details - The project originally planned to cover an area of approximately 47,935 square meters, with a total construction area of 32,880 square meters [1] - The project includes the acquisition of 73 sets of new production equipment and the relocation of 372 sets of existing production equipment [1] - The planned annual production capacity is 4.7255 million open surgical instruments and 19,700 minimally invasive endoscopic surgical instruments [1] Group 2: Equity Structure Changes - The equity structure change is due to the departure of two incentive targets and the retirement of one incentive target from the company's equity incentive plan [1] - The company will acquire the subscribed capital contribution rights and equity from these departing individuals [1] - This change will not affect the company's consolidated financial statements and will not have a substantial impact on the implementation of the fundraising project, aligning with the company's long-term development plan [1]